Mouwasat Medical Services Co (SAU:4002) Cyclically Adjusted Revenue per Share: ﷼12.90 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SAU:4002 Mouwasat Medical Services Co SAU:4002
100 GF Score
Price ﷼62.65
GF Value ﷼110.07
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Mouwasat Medical Services Co Cyclically Adjusted Revenue per Share?

Mouwasat Medical Services Co SAU:4002 +0.72% 100 Cyclically Adjusted Revenue per Share is ﷼12.90 as of Mar. 2026. GuruFocus rates SAU:4002 with a GF Score™ of 100/100 and a GF Value™ of ﷼110.07 (Significantly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Mouwasat Medical Services Co's adjusted revenue per share for the three months ended in Mar. 2026 was ﷼4.169. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ﷼12.90 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Mouwasat Medical Services Co's average Cyclically Adjusted Revenue Growth Rate was 11.40% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 12.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Mouwasat Medical Services Co was 12.90% per year. The lowest was 11.30% per year. And the median was 12.60% per year.

As of today (2026-08-02), Mouwasat Medical Services Co's current stock price is ﷼62.65. Mouwasat Medical Services Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was ﷼12.90. Mouwasat Medical Services Co's Cyclically Adjusted PS Ratio of today is 4.86.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Mouwasat Medical Services Co was 14.70. The lowest was 4.67. And the median was 10.90.


Mouwasat Medical Services Co  (SAU:4002) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Mouwasat Medical Services Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=62.65/12.90
=4.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Mouwasat Medical Services Co was 14.70. The lowest was 4.67. And the median was 10.90.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Mouwasat Medical Services Co Cyclically Adjusted Revenue per Share Related Terms


Mouwasat Medical Services Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Mouwasat Medical Services Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mouwasat Medical Services Co Cyclically Adjusted Revenue per Share Chart

Mouwasat Medical Services Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.85 9.02 10.09 11.22 12.45

Mouwasat Medical Services Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.58 11.90 12.22 12.45 12.90

SAU:4002 vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Mouwasat Medical Services Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mouwasat Medical Services Co Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mouwasat Medical Services Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Mouwasat Medical Services Co's Cyclically Adjusted PS Ratio falls into.


SAU:4002
100GF Score
Mouwasat Medical Services Co SAU:4002
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mouwasat Medical Services Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mouwasat Medical Services Co's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.169/330.2130*330.2130
=4.169

Current CPI (Mar. 2026) = 330.2130.

Mouwasat Medical Services Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 1.501 241.018 2.056
201609 1.401 241.428 1.916
201612 1.764 241.432 2.413
201703 1.815 243.801 2.458
201706 1.766 244.955 2.381
201709 1.797 246.819 2.404
201712 2.157 246.524 2.889
201803 2.112 249.554 2.795
201806 1.972 251.989 2.584
201809 2.021 252.439 2.644
201812 2.280 251.233 2.997
201903 2.313 254.202 3.005
201906 2.231 256.143 2.876
201909 2.216 256.759 2.850
201912 2.525 256.974 3.245
202003 2.470 258.115 3.160
202006 2.348 257.797 3.008
202009 2.744 260.280 3.481
202012 2.668 260.474 3.382
202103 2.671 264.877 3.330
202106 2.627 271.696 3.193
202109 2.661 274.310 3.203
202112 2.762 278.802 3.271
202203 2.835 287.504 3.256
202206 2.780 296.311 3.098
202209 2.741 296.808 3.049
202212 3.301 296.797 3.673
202303 3.321 301.836 3.633
202306 3.125 305.109 3.382
202309 3.197 307.789 3.430
202312 3.865 306.746 4.161
202403 3.614 312.332 3.821
202406 3.436 314.175 3.611
202409 3.554 315.301 3.722
202412 3.778 315.605 3.953
202503 3.822 319.799 3.946
202506 3.961 322.561 4.055
202509 3.887 324.800 3.952
202512 4.423 324.054 4.507
202603 4.169 330.213 4.169

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ﷼12.90 mean?
Mouwasat Medical Services Co (SAU:4002) has a Cyclically Adjusted Revenue per Share of ﷼12.90 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Mouwasat Medical Services Co and its competitors.
Is Mouwasat Medical Services Co's Cyclically Adjusted Revenue per Share too high?
Mouwasat Medical Services Co's current Cyclically Adjusted Revenue per Share is ﷼12.90. Overall, Mouwasat Medical Services Co has a GF Score™ of 100/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Mouwasat Medical Services Co's Cyclically Adjusted Revenue per Share of ﷼12.90 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Mouwasat Medical Services Co and its competitors. Mouwasat Medical Services Co's current Cyclically Adjusted Revenue per Share is ﷼12.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼110.07, compared to a current price of ﷼62.65 — trading 43.1% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ﷼12.90. Mouwasat Medical Services Co's overall GF Score™ is 100/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current Cyclically Adjusted Revenue per Share is ﷼12.90 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?

Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued. The current stock price of ﷼62.65 is trading 43.1% below its estimated GF Value™ of ﷼110.07. GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.

Key valuation signals for SAU:4002:

  • Cyclically Adjusted Revenue per Share: ﷼12.90
  • GF Value™: ﷼110.07 vs. price of ﷼62.65 (43.1% below fair value)
  • GF Score™: 100/100 with 5 warning signs

No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mouwasat Medical Services Co Business Description

Address Destect 71, King Fahad Road, P.O. Box 282, Dammam, SAU, 31411
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
100GF Score

Get the complete analysis for SAU:4002

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

﷼62.65
Price
﷼110.07
GF Value